The weight loss landscape has transformed dramatically. What was once a choice between dieting or expensive brand-name medications like Wegovy and Zepbound has exploded into a crowded marketplace of telehealth platforms, compounding pharmacies, and direct-to-consumer services. By 2026, patients have more options than ever—but also more confusion.

If you are considering GLP-1 medications for weight loss, understanding the provider landscape is essential. This guide breaks down the different types of providers, compares the major platforms, and helps you navigate the critical decisions around cost, safety, and clinical oversight.

The Two Paths: Brand-Name vs. Compounded Medications
Before comparing providers, you need to understand the fundamental divide in how GLP-1 medications are obtained.

Brand-Name Medications
FDA-approved brand-name GLP-1s include:

Wegovy and Ozempic (semaglutide, from Novo Nordisk)

Zepbound and Mounjaro (tirzepatide, from Eli Lilly)

These medications have undergone rigorous clinical trials proving their safety and efficacy. The landmark STEP 1 trial for Wegovy showed average weight loss of 14.9% after 68 weeks, while Zepbound demonstrated approximately 20.9% weight loss in the SURMOUNT program.

The major downside is cost. Without insurance, brand-name GLP-1s run approximately
1
,
000
t
o
1,000to1,350 per month. The TrumpRx initiative launched in May 2026 aims to reduce these prices to around $350 per month for qualifying cash-pay patients, but insurance remains a separate issue.

Compounded Medications
Compounded GLP-1s are custom-made versions produced by licensed pharmacies when brand-name drugs are in shortage or when a patient needs a formulation (like a different dose or delivery method) that is not commercially available.

Critical caveat: Compounded medications are not FDA-approved. They have not undergone the same rigorous testing for safety, effectiveness, or quality control. The FDA has issued warning letters to multiple telehealth companies regarding misleading claims about compounded GLP-1s.

However, compounded options are significantly more affordable, typically ranging from
129
t
o
129to399 per month. This price difference has driven massive growth in the telehealth space.

The 2026 Regulatory Shift
As of April 2026, the FDA has formally proposed removing semaglutide, tirzepatide, and liraglutide from the 503B bulks list, effectively ending large-scale compounding because the shortages are considered resolved. Several major compounding labs ceased production in early 2026. A public comment period remains open through June 29, 2026, but the era of widespread compounded GLP-1 access may be ending.

Major Telehealth Providers Compared
Ro (Ro.co)
Best for: Clinical depth and insurance navigation

Ro offers both brand-name and compounded GLP-1 options through its "Ro Body" program. The platform requires a
145
p
e
r
m
o
n
t
h
m
e
m
b
e
r
s
h
i
p
f
e
e
∗
∗
,
w
i
t
h
m
e
d
i
c
a
t
i
o
n
c
o
s
t
s
o
n
t
o
p
—
t
y
p
i
c
a
l
l
y
b
r
i
n
g
i
n
g
t
o
t
a
l
m
o
n
t
h
l
y
c
o
s
t
s
t
o
∗
∗
145permonthmembershipfee∗∗,withmedicationcostsontop—typicallybringingtotalmonthlycoststo∗∗300–$400+.

What stands out: Ro provides more comprehensive clinical support than most competitors, including metabolic health coaching, body composition tracking, and structured follow-up. The platform also helps navigate insurance prior authorizations.

User feedback: Forbes Health testers rated Ro highly for onboarding (5/5) but noted frustrating communication delays, sometimes taking two to three days to receive responses about insurance issues. A tester described feeling "frustrated, misled, and unsure about the service's reliability."

Bottom line: Ro is best for patients who prioritize clinical oversight and have insurance worth fighting for. It is not the cheapest option.

Hims & Hers
Best for: Established brand with broad service range

Hims & Hers is a publicly traded telehealth company offering compounded semaglutide starting around $199 per month. The platform also announced a March 2026 collaboration with Novo Nordisk to offer branded Wegovy.

What stands out: The platform has strong name recognition and offers services across multiple health categories (weight loss, ED treatment, hair loss). The Novo Nordisk partnership signals a pivot toward branded medication access.

Regulatory concerns: Hims received an FDA warning letter in September 2025 and was referred to the Department of Justice for investigation of potential federal law violations related to compounded semaglutide.

Bottom line: A major player with brand recognition, but regulatory scrutiny means patients should carefully review what they are actually receiving.

Found Health
Best for: Medication flexibility and insurance support

Found Health stands out for having the broadest medication formulary in the industry—covering everything from brand-name Wegovy and Zepbound to compounded options and non-GLP-1 alternatives like metformin and Contrave.

Pricing structure: Monthly membership costs
99
–
99–149, with medication costs separate. Compounded semaglutide runs approximately
200
–
200–300 per month on top of the membership.

The catch: Found requires a 6-month commitment with a $99 early cancellation fee—a source of significant customer complaints. The Better Business Bureau shows repeated complaints from users who did not realize they were locked in.

Bottom line: Best for patients with insurance who need flexibility across multiple medication options. Not the cheapest cash-pay choice.

WeightWatchers Clinic
Best for: Comprehensive program integration

WeightWatchers Clinic (formerly Sequence) integrates GLP-1 medications with the company's established behavioral weight loss program. Membership costs $74 per month with a one-year commitment, and certain medications are included in the price.

What stands out: Providers are obesity specialists, and the program includes workshops, dietitian access, and community support. Forbes Health testers gave the platform a perfect 5/5 rating for onboarding and ease of use.

Drawbacks: Pricing information is not easily accessible on the website, and cancellation policies are restrictive.

Bottom line: Best for patients who want a structured program beyond just medication access.

Mochi Health
Best for: User experience and transparent pricing

Mochi Health earned a 4.3-star rating from Forbes Health for its straightforward user experience. Membership costs
79
p
e
r
m
o
n
t
h
∗
∗
,
w
i
t
h
c
o
m
p
o
u
n
d
e
d
s
e
m
a
g
l
u
t
i
d
e
a
v
a
i
l
a
b
l
e
f
o
r
a
n
a
d
d
i
t
i
o
n
a
l
∗
∗
79permonth∗∗,withcompoundedsemaglutideavailableforanadditional∗∗99 per month and compounded tirzepatide for $199 per month.

What stands out: The AI chatbot provides instant, transparent pricing—no phone calls or lengthy intake forms required. Forbes Health testers described the experience as "surprisingly simple" and praised the personalized approach.

Medication options: Mochi prescribes both brand-name and compounded options. Brand-name medications must be filled at a local pharmacy; compounded medications are shipped directly.

Bottom line: Best for patients who value a smooth, transparent user experience and competitive compounded pricing.

Direct Meds
Best for: All-inclusive transparent pricing

Direct Meds offers compounded semaglutide starting around
197
–
197–297 per month and tirzepatide starting at
349
–
349–497 per month—with no separate membership fee.

What stands out: The pricing is fully inclusive—medication, supplies, telehealth consultations, and shipping are bundled. The platform offers both injectable and sublingual (under-the-tongue) formulations, which is unusual for patients with needle aversion.

Clinical model: Asynchronous consultations reviewed by licensed providers. The platform is LegitScript-certified and partners with 503A compounding pharmacies CraftedRx and ChemistryRx.

Regulatory status: Direct Meds received an FDA warning letter in September 2025 as part of a mass enforcement action—but the letter addressed marketing language, not medication safety.

Bottom line: Best for patients who want simple, all-inclusive pricing without membership fees or billing surprises.

Henry Meds
Best for: Budget-focused compounded access

Henry Meds advertises compounded semaglutide starting at $99 per month—the most aggressive entry price in the market. However, whether this rate applies at therapeutic doses or only during initial titration is worth confirming before enrolling.

What stands out: Lower profile than competitors means less regulatory attention, but also less public data for verification. The service uses a straightforward subscription model with asynchronous consultations.

Bottom line: Best for patients whose primary concern is lowest possible monthly cost—but verify the fine print on dosing tiers.

IVIM Health
Best for: Cheapest cash-pay membership

IVIM Health charges $75 per month for telehealth membership (with the first month free) and focuses primarily on Wegovy and compounded semaglutide. If you are paying cash and want the lowest possible entry cost, IVIM is a strong contender.

Red Flags to Watch For
1. Asynchronous-Only Consultations
Many online providers do not require a video visit before prescribing GLP-1s. Dr. Kevin Gendreau, a dual board-certified obesity medicine physician, warns that "your telehealth visit should feel like a real visit in a doctor's office, where the provider has a plan for accountability and ongoing follow-up care".

2. Lack of Lab Testing
Reputable providers should check bloodwork at the start of treatment and again at six months. This helps detect underlying conditions like hypothyroidism or diabetes and monitors for issues like muscle loss or dehydration.

3. No Quality Documentation
If you are using compounded medications, the pharmacy should provide a Certificate of Analysis (CoA) proving the product has been tested for quality and safety. The pharmacy should also be accredited by the Pharmacy Compounding Accreditation Board (PCAB).

4. Unclear Cancellation Policies
Found Health's $99 early cancellation fee and 6-month commitment have generated numerous complaints. Read the fine print before providing payment information.

How to Choose the Right Provider
If your priority is lowest monthly cost: Henry Meds or IVIM Health offer the most aggressive entry pricing. Verify what dose that price covers.

If you want transparent, all-inclusive pricing: Direct Meds bundles everything with no separate membership fee.

If you have insurance and want help navigating it: Found Health or Ro offer the strongest insurance support and medication flexibility.

If you want a comprehensive program beyond medication: WeightWatchers Clinic integrates medication with behavioral support, coaching, and community.

If you prioritize brand-name FDA-approved medications: Ro, Found, and Hims (through its Novo Nordisk partnership) offer branded options, but prepare for higher costs.

If user experience and transparent pricing matter most: Mochi Health's AI chatbot and straightforward structure stand out.